溶血尿毒综合征

溶血尿毒综合征患儿MCP基因突变分析

Analysis of MCP Mutations in 9 Chinese Children with Hemolytic Uremic Syndrome

目的溶血尿毒综合征（Hemolyticuremicsyndrome，HUS）是一种以溶血性贫血、血小板减少和肾功能衰竭三联征为主要临床特点的疾病。

Objective Hemolytic uremic syndrome ( HUS ) is characterized by the triad of thrombocytopenia , microangiopathic hemolytic anemia and acute renal failure .

H因子突变与非典型性溶血尿毒综合征

Relationship between Complement Factor H Mutation and Atypical Hemolytic Uremic Syndrome

方法：对我院近年收治的15例溶血尿毒综合征（HUS）患儿的临床表现、治疗、护理状况进行总结分析。

Methods : Analyse 15 cases HUS clinical syndrome , therapy and nurse .

目的对溶血尿毒综合征（HUS）患儿进行膜辅助蛋白（MCP）基因突变分析。

Objectives To investigate genetic mutation of membrane cofactor protein ( MCP ) in patients with hemolytic uremic syndrome ( HUS ) .

为进一步提高小儿危重型溶血尿毒综合征（HUS）的诊治水平，总结了3例病人在6次住院中抢救成功的经验。

In order to improve the diagnosis and treatment of severe hemolytic uremic syndrome ( SHUS ), we summarized the rescuing experiences in 3 children with SHUS .

小儿危重型溶血尿毒综合征的抢救治疗

Experiences of rescue of children suffering from severe hemolytic uremic syndrome

43例儿童溶血尿毒综合征的输血治疗

Treatment of blood transfusion in 43 children with hemolytic-uremic syndrome

血浆置换治疗小儿溶血尿毒综合征疗效及随访研究

The treatment of plasma exchange for the children with hemolytic-uremic syndrome and follow-up

影响儿童溶血尿毒综合征预后相关因素及治疗探讨

Exploration of prognostic correlation factors and treatment of hemolytic uremic syndrome in children

目的：探讨小儿溶血尿毒综合征救护体会。

Objective : To probe rescue and nurse on children with hemolysis and uraemia syndrome .

35年来小儿溶血尿毒综合征流行概况、死亡病例分析和治疗进展

The epidemic survey of children with hemolytic uremic syndrome ( HUS ), analysis of the death cases and therapeutic advance in 35 years in Beijing Children 's Hospital

各个国家都在持续报告溶血性尿毒综合征（HUS）和肠出血性大肠杆菌（EHEC）的病例。

Countries continue to report cases of haemolytic uraemic syndrome ( HUS ) and enterohemorrhagic E. coli ( EHEC ) .

溶血性尿毒综合征（HUS）以及肠出血性大肠杆菌（EHEC）病例在德国持续上升。

Cases of haemolytic uraemic syndrome ( HUS ) and enterohemorrhagic E.coli ( EHEC ) continue to rise in Germany .

肠道出血性大肠杆菌（EHEC）是一类能够引起人类出血性结肠炎或溶血性尿毒综合征的致病性大肠杆菌。

Enterohemorrhagic Escherichia coli ( EHEC ) are a subset of pathogenic E. coli that can cause hemorrhagic colitis or hemolytic uremic syndrome in humans .

大肠埃希菌O157：H7相关的溶血性尿毒综合征患儿中降钙素原的作用

Procalcitonin in children with Escherichia coli O157 : H7 associated hemolytic uremic syndrome

截至2011年5月31日，德国有9个病人死于溶血性尿毒综合征，有6个病人死于肠出血性大肠杆菌感染。

As of31 May2011 , nine patients in Germany have died of HUS , and six of EHEC .

溶血性尿毒综合征的并发症可能在医治腹泻后发生，进而可引起急性肾功能衰竭。

The complication of HUS can cause acute kidney failure and can develop after the diarrhoea has resolved .

就欧洲的总体情况而言，已报告发生499例溶血性尿毒综合征病例以及1115例肠出血性大肠杆菌感染病例，总数为1614例。

Overall in Europe , 499 cases of HUS and1115 cases of EHEC have been reported , 1614 in total .

溶血性尿毒综合征是由特定大肠杆菌感染引起的并发症，可导致肾功能衰竭。

HUS , which can lead to kidney failure , is a complication of an infection by particular Escherichia coli bacteria .

这种叫O104：H4型的大肠杆菌能造成出血性腹泻，痉挛，以及更为致命的溶血性尿毒综合征症状，引发肾衰竭。

Type O104 : H4 can cause bloody diarrhoea , convulsions and , most lethally , haemolytic-uraemic syndrome , which attacks the kidneys .

其它一些国家也通报了病例，尤其是瑞典通报了10例溶血性尿毒综合征，两例重症监护病例。

Some other countries have reported cases , notably Sweden , which has reported ten HUS cases , with two in intensive care .

引起严重的临床症状，包括出血性肠炎、溶血性尿毒综合征和血小板减少性紫癜。

They can result in severe clinical manifestations , including haemorrhagic colitis , haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura , symptoms associated with high morbidity and mortality .

溶血性尿毒综合征是一种危及生命的疾病，其特征是急性肾功能衰竭（尿毒症）、溶血性贫血以及低血小板（血小板减少症）。

Haemolytic uraemic syndrome ( HUS ) is a life-threatening disease characterized by acute renal failure ( uraemia ), haemolytic anaemia , and a low platelet count ( thrombocytopenia ) .

它源于感染肠出血性大肠杆菌，据估计，在受肠出血性大肠杆菌感染的患者中，多达10%的患者患溶血性尿毒综合征，死亡率可高达5%。

It results from EHEC infection , and it is estimated that up to10 % of EHEC-affected patients may develop HUS , with a mortality rate ranging up to5 % .